The present study was designed to test the hypothesis that scorpion venom analgesic peptide, BmK AGAP inhibits cancer stemness and epithelial-mesenchymal transition by down-regulating PTX3 expression in breast cancer. This evidence concerns the gene PTX3 and breast carcinoma.